Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Meei-Wah Chan"'
Autor:
Ryan Leow, Tony Yi-Wei Li, Meei-Wah Chan, William K. F. Kong, Siew-Pang Chan, Kian-Keong Poh, Ivandito Kuntjoro, Ching-Hui Sia, Tiong-Cheng Yeo
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Yeo’s index, the product of the mitral leaflet separation index and dimensionless index of mitral valve (MV), was recently described to accurately identify severe rheumatic mitral stenosis (MS). We assess the association between Yeo’s in
Externí odkaz:
https://doaj.org/article/bb3bfee942e347839e18d0bfb95d7a05
Autor:
Tony Li, Ryan Leow, Meei Wah Chan, William K. F. Kong, Ivandito Kuntjoro, Kian Keong Poh, Ching Hui Sia, Tiong Cheng Yeo
Publikováno v:
Diagnostics, Vol 14, Iss 15, p 1595 (2024)
Background: Net atrioventricular compliance (Cn) can affect the accuracy of mitral valve area (MVA) assessment. We assessed how different methods of MVA assessment are affected by Cn, and if patients with abnormal Cn may be identified by clinical and
Externí odkaz:
https://doaj.org/article/d59dfd1b36e54d26828e3884e4c00419
Autor:
Tony Li, Ryan Leow, Meei Wah Chan, William K. F. Kong, Ivandito Kuntjoro, Kian Keong Poh, Ching Hui Sia, Tiong Cheng Yeo
Publikováno v:
Diagnostics, Vol 14, Iss 13, p 1440 (2024)
Background: Yeo’s index is a novel measure of the severity of rheumatic mitral valve stenosis (MS). It is derived from the product of the mitral leaflet separation index and dimensionless index. This study aims to validate Yeo’s index using a tra
Externí odkaz:
https://doaj.org/article/0cad680807ee443692ed1a051ec7aad0
Publikováno v:
Journal of the American College of Cardiology. 81:S300-S304
Publikováno v:
Journal of the American College of Cardiology. 81:S393-S395
Autor:
Meei Wah Chan, Anwar Irawan Ruhani
Publikováno v:
Journal of the American College of Cardiology. 79:S163-S165
Publikováno v:
International journal of clinical pharmacy. 41(5)
Background Hyperphosphatemia is a common consequence in end stage renal disease. It is associated with increased cardiovascular risk and mortality, also development of hyperparathyroidism and mineral bone disease. A patient educational program involv